Package Insert: Information for the Patient
OmeprazoleAurovitas Pharma20 mg Hard Gastroresistant Capsules EFG
Read this entire package insert carefully before starting to take this medication, as it contains important information for you.
Follow exactly the administration instructions for the medication contained in this package insert or those indicated by your doctor or pharmacist.
-Keep this package insert, as you may need to refer to it again.
-If you need advice or more information, consult your pharmacist.
-If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this package insert. See section 4.
-You should consult a doctor if your symptoms worsen or do not improve after 14 days.
1.What is Omeprazole Aurovitas Pharma and what it is used for
2.What you need to know before starting to take Omeprazole Aurovitas Pharma
3.How to take Omeprazole Aurovitas Pharma
4.Possible adverse effects
5.Storage of Omeprazole Aurovitas Pharma
6.Contents of the package and additional information
This medicationcontains omeprazole as its active ingredient. It belongs to a group of medications known as “proton pump inhibitors”. These medications work by reducing the amount of acid produced by the stomach.
Omeprazole is indicated in adults for the short-term treatment of symptoms of reflux (for example, heartburn, acid regurgitation).
Reflux is the backflow of acid from the stomach into the esophagus, which can become inflamed and painful. This can cause symptoms such as a burning sensation in the chest that rises up to the throat (heartburn) and a sour taste in the mouth (acid regurgitation).
You may need to take the capsules for 2-3 consecutive days to achieve an improvement in symptoms.
You should consult a doctor if symptoms worsen or do not improve after 14 days.
Do not take Omeprazol Aurovitas Pharma:
Do not take omeprazole if you fall into any of the above cases. If you are unsure, speak with your doctor or pharmacist before taking omeprazole.
Warnings and precautions
Consult your doctor or pharmacist before starting to take omeprazole.
Do not take omeprazole for more than 14 days without consulting your doctor. If you do not experience relief, or if you feel that your symptoms worsen, consult your doctor.
This medication may mask the symptoms of other diseases. Therefore, consult your doctor immediately if you experience any of the following symptoms before starting to take omeprazole or during treatment:
If you experience a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt omeprazole treatment. Remember to mention any other symptoms you may notice, such as joint pain.
When taking omeprazole, inflammation in the kidneys may occur. Signs and symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. Inform your doctor of these signs.
Patients should not take omeprazole as preventive medication.
Taking Omeprazol Aurovitas Pharma with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including those purchased without a prescription. Omeprazole may affect the mechanism of action of some medications, and some medications may affect omeprazole.
Do not take omeprazole if you are taking a medication that containsnelfinavir(used to treat HIV infection).
You must inform your doctor specifically if you are takingclopidogrel(used to prevent blood clots).
Inform your doctor or pharmacist if you are taking any of the following medications:
Taking Omeprazol Aurovitas Pharmawith food and drinks
You can take your capsules with food or on an empty stomach. Do not chew or crush the capsules. Swallow the capsules whole with a glass of water.
Pregnancy and breastfeeding
Before taking omeprazole, inform your doctor if you are pregnant or trying to become pregnant. Your doctor will decide if you can take omeprazole during this time.
Your doctor will decide if you can take omeprazole if you are breastfeeding.
Driving and using machines
Omeprazole is unlikely to affect your ability to drive or use tools or machines.
Adverse effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or use machines.
Omeprazol Aurovitas Pharma contains Saccharose
This medication contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Omeprazol Aurovitas Pharma contains Sodium
This medication contains less than 1 mmol sodium (23 mg) per capsule; it is essentially “sodium-free”.
The recommended dose is one 20 mg capsule once a day for 14 days. Contact your doctor if symptoms do not disappear after this time.
You may need to take the capsules for 2-3 consecutive days to achieve an improvement in symptoms.
How to take this medication
What to do if you have trouble swallowing the capsules
If you take moreOmeprazole Aurovitas Pharmathan you should
If you have taken more omeprazole than recommended, consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to takeOmeprazole Aurovitas Pharma
If you forgot to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to compensate for the missed doses.
If you experience any of the following rare but serious side effects, stop takingomeprazoleand consult your doctor immediately:
Other side effects are:
Frequent side effects(may affect up to 1 in 10 people)
Less frequent side effects (may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Side effects of unknown frequency(cannot be estimated from available data)
In very rare cases, omeprazole may affect white blood cells in the blood and cause immunodeficiency. If you experience an infection with symptoms such as fever with a very poor general condition or fever with symptoms of local infection, such as neck pain, throat pain, or mouth pain or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential to provide information about the medication you are taking at that time.
Do not worry about this list of possible side effects. You may not experience any of them. If you consider any of the side effects you are experiencing to be severe or if you experience any side effect not mentioned in this prospectus, inform your doctor or pharmacist.
Reporting side effects
If you experience any type ofside effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es.By reporting side effects, you can contribute to providing more information about the safety of this medication.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition ofOmeprazol Aurovitas Pharma
Content of the capsule: sugar spheres (sucrose and cornstarch), sodium lauryl sulfate, disodium phosphate, mannitol, hypromellose, macrogol 6000, talc, polysorbate 80, titanium dioxide, and a 30% dispersion of a copolymer of methacrylic acid-ethyl acrylate (1:1).
Capsule coating: gelatin, quinoline yellow, and titanium dioxide.
Appearance of the product and content of the packaging
The gastro-resistant capsules of Omeprazol Aurovitas Pharma 20 mg are yellow opaque, containing white to cream-colored microspheres.
Aluminum blister: 14 capsules.
HDPE bottles with silica gel desiccant in the polypropylene cap: 14 capsules.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Responsible manufacturer:
Laboratorios Liconsa, S.A
Av. Miralcampo nº 7, Industrial Estate Miralcampo
19200 Azuqueca de Henares, Guadalajara
Spain
Last review date of this leaflet:November 2023
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.